title: T-type calcium channel trigger p21ras signaling pathway to ERK in Cav3.1-expressed HEK293 cells.
abstract: We constructed a new cell line which stably expressed Cav3.1 and Kir2.1 subunits in HEK293 cells (HEK293/Cav3.1/Kir2.1) in order to investigate the unknown cellular signaling pathways of T-type voltage-dependent calcium channels. The new cell line has a stable resting membrane potential and can activate T-type Ca(2+) channels by KCl-mediated depolarization. We showed that Cav3.1 activation resulted in the level of p21(ras)-GTP in the cells being rapidly decreased during the first 2 min, and then recovering between 2 min and 15 min. The kinetics of ERK activation following Cav3.1 stimulation was also investigated. ERK activation was decreased from 2 min to 5 min after KCl stimulation, which means that Cav3.1 activation reduced ERK activity in the very early stages of activation. In addition, similar results for Cav3.1 activation were also shown in the case of Sos1, Grb2, and Shc, which means that Cav3.1 activation triggers p21(ras) and that this signal is transferred to ERK by Sos1, Grb2, and Shc.
authors.affiliation: Biomedical Research Center, Korea Institute of Science and Technology, Seoul, Korea.
authors.forename: Juhyun
authors.initials: J
authors.lastname: Choi
authors.forename: Jong-Hwa
authors.initials: JH
authors.lastname: Park
authors.forename: Oh Yeun
authors.initials: OY
authors.lastname: Kwon
authors.forename: Sunoh
authors.initials: S
authors.lastname: Kim
authors.forename: Ji Hyung
authors.initials: JH
authors.lastname: Chung
authors.forename: Dae Sik
authors.initials: DS
authors.lastname: Lim
authors.forename: Key Sun
authors.initials: KS
authors.lastname: Kim
authors.forename: Hyewhon
authors.initials: H
authors.lastname: Rhim
authors.forename: Ye Sun
authors.initials: YS
authors.lastname: Han
mesh_terms: D015153:Blotting, Western / Q000379:methods; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology; D020747:Calcium Channels, T-Type / Q000378:metabolism*; D002460:Cell Line; D003001:Cloning, Molecular / Q000379:methods; D004347:Drug Interactions; D004789:Enzyme Activation / Q000187:drug effects; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D047468:Immunoprecipitation / Q000379:methods; D042541:Intracellular Space / Q000187:drug effects / Q000378:metabolism; D020748:Mibefradil / Q000494:pharmacology; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D015689:Oncogene Protein p21(ras) / Q000378:metabolism*; D010766:Phosphorylation / Q000187:drug effects; D024661:Potassium Channels, Inwardly Rectifying / Q000378:metabolism; D011189:Potassium Chloride / Q000494:pharmacology; D015398:Signal Transduction / Q000502:physiology*; D013997:Time Factors; D018909:src Homology Domains / Q000502:physiology
chemical_list: C121855:CACNA1G protein, human; D002121:Calcium Channel Blockers; D020747:Calcium Channels, T-Type; C489461:Kir2.1 channel; D024661:Potassium Channels, Inwardly Rectifying; D020748:Mibefradil; D011189:Potassium Chloride; D020928:Mitogen-Activated Protein Kinases; D015689:Oncogene Protein p21(ras); D002118:Calcium